The Metabolic Classroom with Dr. Ben Bikman

Questions? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: GLP-1 medications help reduce appetite, while low-carbohydrate diets help lower insulin and support fat burning, making them potentially complementary approaches to weight loss and metabolic health. Ben explains how combining low-dose medication with better food choices may help preserve muscle, improve metabolic markers, and build lasting habits that make it easier to maintain progress after treatment. Summary: In this mini lecture, Dr. Bikman explains why GLP-1 medications and low-carbohydrate diets may work better together than either approach alone. GLP-1 drugs help people feel less hungry and eat less, while reducing carbohydrates—especially refined sugars and starches—helps lower insulin and improve the body's ability to burn stored fat. Ben argues that these approaches address different parts of the same metabolic problem.…

Questions? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Summary: Dr. Ben Bikman explains the surprising relationship between potassium, insulin, and blood sugar control. Potassium is an essential mineral that helps cells maintain their electrical activity, and insulin plays an important role in moving potassium from the bloodstream into cells. But the relationship works both ways: when potassium levels become too low, the pancreas may struggle to release enough insulin, potentially causing blood sugar to rise. Ben also explores the role of aldosterone, a hormone that tells the kidneys to retain sodium while releasing potassium. When aldosterone levels are too high, potassium loss can increase, insulin production may suffer, and blood pressure can rise. He reviews research linking lower potassium levels—even within the normal laboratory range—to an increased risk of developing type 2 diabetes.…

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Summary: Dr. Bikman explains why losing a large amount of weight can sometimes cause the body's metabolism to slow down more than expected. He uses contestants from The Biggest Loser as an example. Six years after their dramatic weight loss, many had regained much of the weight, yet their bodies were still burning approximately 500 fewer calories per day than expected for their size. This phenomenon is called metabolic adaptation. Ben explains how hormones such as leptin, insulin, and thyroid hormone influence this process. As body fat decreases, leptin falls, signaling the brain to increase hunger and conserve energy. The body may also reduce spontaneous movement and other energy-consuming activities, making it increasingly difficult to maintain weight loss. The encouraging news is that the way someone loses weight can make a difference.…

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Dr. Bikman explains why micronized progesterone should not be confused with the synthetic progestins historically used in many hormone therapies. Micronized progesterone is chemically identical to the hormone produced naturally by a woman’s ovaries, while synthetic progestins can also activate cortisol- or testosterone-related receptors, potentially affecting insulin sensitivity, blood lipids, and other aspects of metabolic health. Ben reviews clinical evidence showing that micronized progesterone can effectively protect the uterine lining when estrogen is used while preserving more of estrogen’s favorable metabolic effects. Oral micronized progesterone is also converted into allopregnanolone, which enhances the brain’s calming GABA signaling and may improve sleep. Better sleep itself can support insulin sensitivity, while progesterone may…

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Summary: Dr. Bikman explains why some people may produce an inadequate GLP-1 response and how insulin resistance could be part of the problem. Because intestinal L cells have insulin receptors, chronically elevated insulin can make these cells insulin resistant, reducing their ability to release GLP-1 and potentially creating a cycle of faster stomach emptying, higher glucose, more insulin, and further impairment of the natural GLP-1 response. Ben uses this physiology to explain how he believes GLP-1 medications should be used: not simply to produce maximum weight loss, but as a temporary window in which carbohydrate cravings become easier to control. Rather than escalating automatically to the highest tolerated dose, he favors using the lowest dose that makes refined carbohydrates easier to resist while still requiring the person to…

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Continuous glucose monitoring shows how the body handles glucose, but it cannot reveal how much insulin was required to produce that glucose response. By continuously measuring ketones alongside glucose, the new dual sensor may provide an indirect window into insulin activity, fat burning, and metabolic flexibility while also helping people with diabetes detect dangerous ketone elevations earlier. Summary: Dr. Ben Bikman explores a new wearable that continuously measures both glucose and ketones. Unlike a traditional continuous glucose monitor, Abbott’s Libre Duo can track beta-hydroxybutyrate (BHB) alongside glucose, providing another window into what is happening metabolically. For people with diabetes, continuous ketone monitoring could provide earlier warning of dangerous ketoacidosis, particularly in people with type 1 diabetes…

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com In today’s mini-lecture, Dr. Ben Bikman explains the new generation of oral GLP-1 medications and why two drugs that come as pills can work very differently. Oral semaglutide is still a peptide, so it requires a special absorption enhancer to protect it from digestion and help it cross the stomach lining. Even then, only about 1% of the dose reaches the bloodstream, requiring strict instructions about taking it on an empty stomach. Orforglipron, by contrast, is a small molecule rather than a peptide, allowing it to survive digestion and be absorbed much more efficiently without the same restrictions. Ben reviews studies comparing the drugs for blood glucose control, weight loss, side effects, and maintaining weight loss after injectable GLP-1 therapy. But he emphasizes that changing the delivery method does not change the underlying…

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Insulin is one of the body’s most important signals for determining whether you burn glucose or fat: when insulin rises, fat release and fat burning fall, while lower insulin allows stored fat to become available for fuel. This helps explain why reducing carbohydrates can dramatically increase fat oxidation even without changing the body’s basic ability to burn fat. Summary: In this mini-lecture Ben explains what determines whether the body burns glucose or fat for energy. He begins with the Randle cycle, also called the glucose-fatty acid cycle, which describes how these two fuels compete with one another. But Ben emphasizes that simply having fat available does not mean the body will burn it. Insulin plays a major role in deciding which fuel gets used. When insulin rises after eating carbohydrates, it suppresses the release of…

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Mitochondria often struggle in insulin resistance not because they are broken, but because there are fewer of them trying to process too much incoming fuel. Exercise and improved metabolic health remain the most effective ways to build healthier mitochondria, while supplements may provide additional—but smaller—benefits. Summary: In this mini-lecture, Ben explains why mitochondria have become one of the most talked-about topics in health while separating scientific evidence from popular hype. He begins by reviewing how mitochondria convert the energy stored in carbohydrates, fats, and ketones into ATP, the usable energy that powers virtually every function in the body. Along the way, he explains concepts such as glycolysis, the Krebs cycle, the electron transport system, coupling versus uncoupling, and the production of reactive…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Ben challenges one of the most common beliefs about exercise—that its primary purpose is to help people lose weight. While exercise certainly burns calories, he explains that the body quickly adapts by reducing energy expenditure elsewhere and, in many people, increasing appetite. As a result, the amount of weight lost is often much less than simple calorie calculations would predict. Dr. Bikman explains that these adaptations do not mean exercise is ineffective. Instead, they reveal that body weight is the wrong outcome to focus on. Exercise dramatically improves insulin sensitivity, allowing contracting muscles to pull glucose out of the bloodstream without requiring insulin. It also increases the number of glucose transporters in muscle, improves mitochondrial function, reduces dangerous visceral fat, and helps preserve or build muscle mass. The…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Some people stay lean because they burn more fat in muscle, move more without realizing it, or naturally expend more energy throughout the day. Others only appear lean because they store fat inside the liver and around the organs, making metabolic health far more important than appearance alone. Summary: Dr. Bikman explores a common question: Why do some people seem to eat whatever they want and never gain weight? He explains that there isn't one simple answer. Instead, several different metabolic processes can produce the same outward appearance of being lean, even though the underlying health may be very different. The first explanation is fuel partitioning. After a meal, dietary fat can either be stored in fat tissue or burned by muscle. Which tissue "claims" that fat is heavily influenced by the enzyme lipoprotein lipase (LPL), whose…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Dr. Ben Bikman explains why constant hunger is often driven by hormones rather than a lack of willpower. He begins by showing how meals high in rapidly digested carbohydrates can trigger large insulin spikes, causing fuel to move quickly out of the bloodstream and into storage. Even though the body has plenty of stored energy, the brain senses that available fuel has dropped and responds by making you feel hungry again. Ben then explores three key hormones that regulate fullness: GLP-1, leptin, and insulin. Some people produce less GLP-1 after carbohydrate-rich meals, while others become resistant to leptin and insulin in the brain, weakening the signals that normally reduce appetite and cravings. The takeaway is that persistent hunger is often a signaling problem rather than simply a discipline problem. By lowering chronic insulin levels and…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com In this lecture, Dr. Ben Bikman explains why visceral fat is one of the most metabolically dangerous forms of body fat. Unlike subcutaneous fat, which sits under the skin and can be pinched, visceral fat is stored deep inside the abdomen around the organs. Its location matters because visceral fat drains directly into the liver through the portal vein, meaning the fatty acids and inflammatory signals it releases reach the liver first and at high concentration. Dr. Bikman explains that visceral fat is especially harmful because it tends to grow through hypertrophy, meaning existing fat cells get larger rather than new smaller fat cells being created. As these fat cells enlarge, they become insulin resistant and begin leaking fatty acids even when insulin should be suppressing fat release. Those fatty acids can then accumulate in the liver, pancreas,…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Bone is a metabolically active organ that responds to insulin and glucose while releasing hormones that influence the pancreas, fat cells, appetite, and energy use. High glucose and insulin resistance can make bones brittle despite normal density, while resistance training, stable glucose, and good nutrition support both skeletal and metabolic health. Summary: Dr. Bikman explains why bone should be understood as a metabolic organ, not just structural scaffolding. Bone is living tissue that is constantly being broken down and rebuilt by opposing teams of cells, and that remodeling process requires energy, nutrients, and hormonal coordination. Far from being inert, bone responds to metabolic signals such as insulin, glucose, and leptin—and it sends signals back to the rest of the body. Ben focuses first on insulin’s role in bone health. Insulin…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com In this Metabolic Classroom episode, Dr. Bikman explains mitochondrial uncoupling, a process where cells burn fuel without converting all of that energy into usable ATP. Normally, mitochondria are “coupled,” meaning fuel burning is efficiently converted into cellular energy. But when mitochondria become uncoupled, some of that fuel is released as heat instead—like revving a car engine while it’s in park. Ben explains that this process is especially important in fat tissue. White fat is designed for energy storage and tends to be tightly coupled, while brown fat is rich in mitochondria and uncoupling proteins that burn fuel to generate heat. He then connects this physiology to insulin, showing that insulin appears to make fat-cell mitochondria more tightly coupled and efficient, lowering energy expenditure and making storage easier. The opposite…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Amylin is an insulin-sparing satiety hormone released with insulin that slows digestion, restrains glucagon, and helps reduce post-meal glucose spikes. New amylin-based therapies, especially when combined with GLP-1 drugs, may offer powerful weight-loss effects by restoring natural fullness signals rather than forcing insulin higher. Summary: In this lecture, Dr. Bikman explains amylin, a hormone released from the pancreatic beta cell alongside insulin. While insulin helps move nutrients into tissues, amylin works mainly through the brain and digestive tract to increase fullness, slow gastric emptying, restrain post-meal glucagon, and reduce blood sugar spikes without forcing insulin higher. This makes amylin an insulin-sparing hormone and a natural complement to GLP-1. Ben explains why amylin was difficult to turn into a drug: human amylin…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Note: Our friends at SiBio CKM are offering a 5% discount using the code BEN5 at checkout. However, their CKM is not yet available in the United States and Canada. It is currently available in selected countries including the UK, Australia, Ireland, the Netherlands, and Germany. You can view the full list of supported countries on their website. Also, you can submit your email on their website and they will notify you when it becomes available in your region: https://www.sibiosensor.com/BEN5 Summary: Ben explains the four major ways to measure ketones: urine strips, breath analyzers, finger-prick blood meters, and the newer continuous ketone monitor. He begins by reviewing the three ketone bodies produced during fat-based metabolism: acetoacetate, beta-hydroxybutyrate (BHB), and acetone. Each testing method measures a different ketone molecule,…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Retatrutide activates GLP-1, GIP, and glucagon receptors, combining appetite suppression with increased energy expenditure and powerful liver fat reduction. Dr. Bikman argues that its best use is not as a permanent shortcut, but as a tool to help people regain control over food habits and eventually reduce reliance on medication. Summary: Dr. Ben Bikman explains retatrutide, a next-generation metabolic drug that activates three receptors at once: GLP-1, GIP, and glucagon. While semaglutide targets GLP-1 and tirzepatide targets GLP-1 plus GIP, retatrutide adds a third arm through glucagon receptor activation. This makes it distinct because GLP-1 and GIP mainly reduce food intake, while glucagon adds an energy-output effect by increasing fat oxidation, liver fat clearance, and energy expenditure. Dr. Bikman focuses especially on glucagon…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Tirzepatide activates both GLP-1 and GIP receptors, producing weight loss primarily through appetite suppression, slower gastric emptying, reduced cravings, and improved insulin sensitivity—not by forcing the pancreas to make more insulin. Dr. Bikman argues that its best use may be as a temporary tool to help people regain control of food choices and lower the insulin-driving habits that caused metabolic dysfunction. Summary: In this mini-lecture, Dr. Bikman explains tirzepatide, the dual-incretin drug that activates both GLP-1 and GIP receptors. While it is often described as a drug that improves glucose by increasing insulin, Dr. Bikman argues that this explanation misses the bigger metabolic picture. He begins by reviewing the incretin effect, where oral glucose produces a stronger insulin response than the same glucose given intravenously…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Nuclear receptors inside fat cells respond to lipid-soluble signals and help determine whether cells become fat cells and how they store energy. Although drugs, dietary fats, cortisol, and environmental chemicals can influence these receptors, insulin remains the dominant upstream signal controlling fat-cell growth and storage. Summary: Dr. Ben Bikman explains how nuclear receptors influence fat cell development, fat storage, and metabolic health. Nuclear receptors are proteins inside the cell nucleus that respond to small lipid-soluble signals—such as fatty acids, bile acids, thyroid hormone, cortisol, and steroid hormones—and translate those signals into changes in gene expression. In fat cells, these receptors help determine whether a precursor cell becomes a fat cell and how that fat cell behaves once it exists. The main focus is PPAR…

Topic: Peripheral neuropathy is not caused by high glucose alone, but by the combined effects of hyperglycemia, insulin resistance, and glycemic variability. Protecting nerves requires improving insulin sensitivity and reducing glucose swings—not just lowering A1C. Summary: Ben explains why peripheral neuropathy is not simply a “high blood sugar” problem. While hyperglycemia clearly damages nerves, the story is more complex—especially in type 2 diabetes, where intensive glucose control does not prevent neuropathy nearly as well as it does in type 1 diabetes. Dr. Bikman argues that neuropathy is driven by three interacting metabolic forces: chronic hyperglycemia, insulin resistance, and glycemic variability. He begins by defining peripheral neuropathy as damage to the nerves outside the brain and spinal cord, most commonly appearing first in the feet and toes because the longest nerves are often affected earliest. He then explains how excess glucose damages nerves through the sorbitol pathway, oxidative…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: The vagus nerve is a major communication line between the brain and abdominal organs, helping regulate liver glucose output, gut-brain signaling, and pancreatic insulin secretion. When this neural system is disrupted—by obesity, inflammation, surgery, or altered autonomic balance—nutrient handling and metabolic control can suffer. Summary: Dr. Bikman explores the vagus nerve and its role in nutrient handling, with special attention to the pancreas and insulin secretion. The vagus is the major neural pathway connecting the brain to the metabolic organs of the abdomen, including the gut, pancreas, and liver. Rather than acting only as a motor nerve, it is predominantly sensory, constantly relaying information from the viscera back to the brain while also carrying signals downward that shape digestion, glucose regulation, and hormone release. He…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Summary: In this lecture, Dr. Ben Bikman explores how skeletal muscle fiber type influences insulin sensitivity and diabetes risk. While muscle is the body’s largest site of insulin-stimulated glucose disposal, not all muscle behaves the same. Different fiber types carry different amounts of the molecular machinery needed to respond to insulin, take up glucose, store it, and burn it. He begins by distinguishing the two major muscle fiber types: type 1 slow-twitch and type 2 fast-twitch. Type 1 fibers are more oxidative, with greater mitochondrial density, while type 2 fibers are more glycolytic and fatigue more quickly. Importantly, type 1 fibers contain more insulin receptors, GLUT4 transporters, and key enzymes involved in glucose handling, helping explain why a higher proportion of these fibers is associated with better insulin sensitivity. Dr.…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Summary: GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time. Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1? Evidence shows that…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Creatine supports brain function by rapidly regenerating ATP, making it essential for cognitive performance, especially under conditions of stress or low baseline levels. Clinical evidence shows it can improve memory, attention, mood, and resilience—particularly in vegetarians, older adults, women, and sleep-deprived individuals. Summary: Creatine is widely known as a muscle-building supplement, but in this lecture, Dr. Ben Bikman reveals its far more important and underappreciated role in brain function. Creatine acts as a rapid energy buffer through the phosphocreatine system, allowing brain cells to regenerate ATP within milliseconds during periods of high demand. Because the brain has extremely high energy needs and limited energy storage, this system is critical for maintaining cognitive performance, neurotransmitter signaling, and…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Most people think of gum disease as a local dental issue, but this lecture reveals a much broader and more consequential reality. Dr. Ben Bikman explains how the mouth serves as a gateway to systemic inflammation, particularly when periodontal disease allows bacteria and their toxic byproducts to enter the bloodstream. Once this happens, oral pathogens—especially P. gingivalis—can drive chronic inflammation, disrupt mitochondrial function, and contribute directly to insulin resistance. At the mechanistic level, Dr. Bikman outlines several pathways linking oral health to metabolic dysfunction. These include cytokine spillover (where inflammatory signals interfere with insulin signaling), direct degradation of insulin receptors by bacterial enzymes, dysregulation of liver glucose metabolism, and disruption of the gut microbiome. Together, these…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Ivermectin is a Nobel Prize-winning drug with emerging evidence showing it influences mitochondria, inflammation, and metabolic signaling pathways such as AMPK and FXR. While most data is still preclinical, its consistent mechanisms and strong safety record make it a compelling candidate for further research in cancer and metabolic disease. Summary: Ivermectin has become one of the most controversial drugs in recent years, but beneath the political noise lies a compelling scientific story. In this lecture, Dr. Ben Bikman examines ivermectin strictly through the lens of peer-reviewed research, highlighting its origins as a Nobel Prize-winning antiparasitic drug and exploring its expanding role in metabolism, mitochondrial function, inflammation, and cancer biology. A central theme of the lecture is ivermectin’s impact on mitochondria,…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Sleep loss alters key hunger hormones—reducing leptin and increasing ghrelin—while simultaneously activating reward pathways that increase cravings for calorie-dense foods. Because sleep and appetite hormones influence each other in both directions, improving sleep quality may be one of the most powerful tools for regulating hunger and metabolic health. Summary: Sleep is often treated as a simple lifestyle choice, but in reality it is one of the most powerful regulators of appetite and metabolic health. In this lecture, Dr. Ben Bikman explains the intricate hormonal relationship between sleep and hunger, highlighting how even short periods of sleep deprivation can dramatically alter the body’s appetite signals. Key hormones such as leptin and ghrelin shift in opposite directions during sleep restriction—satiety signaling declines while hunger…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Alzheimer’s disease has traditionally been explained by the buildup of amyloid plaques in the brain, but growing evidence suggests this theory does not fully account for the disease or lead to effective treatments. A metabolic perspective proposes that Alzheimer’s may instead be driven by brain insulin resistance, which disrupts neuronal energy metabolism—while the brain’s ability to use ketones as an alternative fuel remains intact, offering potential strategies for prevention and support. Summary: For decades, Alzheimer’s disease has largely been understood through the lens of the amyloid plaque hypothesis, which proposes that sticky protein deposits in the brain trigger neurodegeneration and cognitive decline. In this Metabolic Classroom lecture, Ben explains why that theory is increasingly being questioned. He reviews the historical…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Metabolic disease is driven more by fat cell size and adipose tissue dysfunction than by total body fat. Ethnicity, genetics, and personal fat storage capacity determine when fat becomes metabolically dangerous. Summary: Dr. Bikman explores a profound but underappreciated truth in metabolic health: it is not how much fat you have that determines disease risk — it is how your fat is stored and how large your fat cells become. Using the metabolic paradox between the United States and Singapore as a starting point, Dr. Bikman explains why populations with dramatically different obesity rates can have nearly identical rates of type 2 diabetes. The key insight is that fat mass alone does not determine metabolic health. Instead, the size of individual fat cells and the body’s capacity to safely expand subcutaneous fat storage — what’s called the…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Bile acids are powerful hormone-like signaling molecules that regulate liver fat, glucose production, insulin sensitivity, energy expenditure, inflammation, and GLP-1 release through FXR and TGR5 receptors. Gallbladder function and bile acid signaling play a far greater role in metabolic health than most people realize. Summary: Ben explores a largely overlooked metabolic regulator: bile acids. While bile is commonly understood as a digestive fluid that helps emulsify fats, bile acids are now recognized as powerful hormone-like signaling molecules that influence insulin sensitivity, mitochondrial function, thyroid hormone activation, inflammation, GLP-1 release, and fat cell behavior. Dr. Bikman explains the remarkable efficiency of enterohepatic circulation, where bile acids are reabsorbed and recycled multiple times per day. This recycling…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: LDL cholesterol is a weak predictor of heart disease compared to markers of insulin resistance, metabolic syndrome, and the triglyceride-to-HDL ratio. True cardiovascular risk is driven far more by metabolic dysfunction than by cholesterol numbers alone. Summary: In this episode, Ben challenges the long-standing belief that LDL cholesterol is the primary driver of heart disease. While LDL has dominated cardiovascular conversations for decades, large-scale data show that nearly half of people hospitalized with heart disease have “normal” LDL levels. Instead, the strongest predictors of cardiovascular risk — especially premature heart disease — are markers of metabolic dysfunction, particularly insulin resistance. Measures like the lipoprotein insulin resistance (LP-IR) score, type 2 diabetes status, metabolic syndrome, and even the simple…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Exercise prompts your muscles to release extracellular vesicles — tiny molecular packages that deliver health-boosting instructions to your brain, liver, fat, and more. These signals improve metabolism, reduce inflammation, and may even help reverse insulin resistance and obesity-related damage. Summary: Dr. Ben Bikman explains how extracellular vesicles (ECVs) — tiny biological packages released by cells — are revolutionizing our understanding of how exercise improves metabolic health. These vesicles act like molecular mail, delivering proteins, lipids, and microRNAs from one tissue to another, with effects that include improved insulin sensitivity, enhanced fat burning, and reduced inflammation. When we exercise, our muscles and other tissues release more ECVs, which travel throughout the body delivering beneficial molecular signals to…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: This episode explores how the NAD⁺/NADH ratio acts as a key metabolic switch, where excess NADH—often driven by high glucose intake—leads to insulin resistance and cellular dysfunction. Ben highlights how lifestyle changes, not supplements, offer the most effective way to restore balance and protect metabolic health. Summary: In this mini lecture, Dr. Bikman explains the critical role of the NAD⁺ to NADH ratio in cellular metabolism and its link to insulin resistance. NAD⁺ and NADH function like a cellular battery, cycling between charged and uncharged states to fuel energy production. However, when this balance tips toward excess NADH—as happens with chronic high glucose intake, aging, alcohol consumption, or inactivity—metabolic dysfunction follows. Ben walks through the mechanisms by which a low NAD⁺/NADH ratio disrupts insulin signaling,…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Ben explains how AMPK and mTOR are critical regulators of aging and metabolism, and how their balance can be influenced by diet and lifestyle. Instead of drugs like rapamycin, strategies like carbohydrate restriction and ketosis offer a safer path to optimizing longevity. Summary: In this Metabolic Classroom mini lecture, Dr. Bikman explores two of the most important molecular “switches” that regulate how cells age, grow, and repair themselves: AMPK and mTOR. These pathways operate in a delicate balance—AMPK promotes energy conservation, fat oxidation, and cellular cleanup (autophagy), while mTOR supports cellular growth and protein synthesis. When AMPK is up, mTOR is down, and vice versa. Ben explains how modern lifestyles—especially chronic overnutrition and excess carbohydrate intake—shift this balance toward persistent mTOR activation,…

Listen ad-free by becoming an Insider: https://benbikman.com Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com Nicotine may not be the addictive villain it's made out to be. When separated from cigarette smoke, it shows surprising anti-inflammatory and neurological potential. Summary: In this Metabolic Classroom mini lecture, Dr. Ben Bikman revisits the molecule nicotine—not as an endorsement to use it, but to explore its distinct effects when separated from harmful compounds in cigarettes. Contrary to popular belief, nicotine alone is not highly addictive; tobacco additives like pyrazines likely amplify the addiction seen in cigarettes. Dr. Bikman details nicotine’s anti-inflammatory properties, particularly through activation of the alpha-7 nicotinic acetylcholine receptor, which may help conditions like ulcerative colitis, sepsis, and arthritis. Ben also explores its complex effects on…

Listen ad-free by becoming an Insider: https://www.benbikman.com References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and online, live Office Hours access with Ben. It also includes Ben’s Weekly Research Review Podcast. 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com Topic Today: Ketones, particularly BHB, aren’t just backup fuel—they’re powerful signals that affect inflammation, gene expression, and mitochondrial function. This episode shows how BHB acts like a hormone to enhance metabolic health and cellular resilience. Summary: In this episode of the Metabolic Classroom, Dr. Bikman explores the remarkable role of…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com In this lecture, Dr. Ben Bikman explores the misunderstood role of glucagon, insulin’s often-overlooked metabolic counterpart. While insulin encourages fat storage and glucose uptake, glucagon signals the body to mobilize and burn stored energy. Contrary to popular belief, glucagon does not stimulate fat release from adipose tissue in humans. Instead, its fat-burning effects occur primarily in the liver, where it enhances fatty acid oxidation, ketone production, and energy expenditure. Glucagon’s power lies in shifting the metabolic balance through the insulin-to-glucagon ratio—a key determinant of whether the body stores or burns fat. Ben also unpacks the liver's molecular response to glucagon, including activation of mitochondrial fat-burning enzymes and ketone formation. Human studies now confirm that glucagon increases liver fat…

📢 Become an Insider: https://benbikman.com 📢 Ben’s LPS/Leaky Gut Recommendations: https://us.fullscript.com/plans/insuliniq-leaky-gut-recommendations 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com In this Metabolic Classroom lecture, Ben explains how lipopolysaccharides (LPS)—toxic molecules from gram-negative gut bacteria—can escape into the bloodstream through a compromised intestinal lining, triggering chronic low-grade inflammation and insulin resistance. Dr. Bikman breaks down the roles of tight junction proteins like ZO-1, occludin, and claudins, and explains how the signaling molecule zonulin disrupts these junctions. Zonulin release is often triggered by dysbiosis and dietary components like gluten and fructose. He also highlights how LPS-induced inflammation impairs insulin signaling and promotes ceramide production, contributing to liver fat accumulation and systemic…

📢 To listen ad-free, become an Insider: Ben’s website, https://www.benbikman.com 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com In this episode Dr. Bikman explores the concept of “male menopause,” more accurately termed andropause. While women experience a dramatic hormonal drop-off due to the depletion of ovarian follicles, men experience a gradual decline in testosterone, primarily because their testosterone-producing Leydig cells become less efficient with age. This slow reduction begins in the 30s or 40s, and free testosterone (the biologically active form) declines even faster than total testosterone due to increasing levels of sex hormone-binding globulin (SHBG). The lecture delves into the cellular mechanisms behind this decline, focusing on mitochondrial dysfunction and insulin resistance. Because testosterone synthesis starts with cholesterol being transported into the mitochondria, anything that impairs this transport—like declining STAR and TSPO proteins or…

📢 To listen ad-free, become an Insider: Ben’s website, https://www.benbikman.com 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com In this mini lecture, Dr. Bikman explains the powerful metabolic effects of long-chain omega-3 fatty acids—specifically EPA and DHA—on fat metabolism and muscle growth. Ben starts by clarifying the difference between plant-based ALA and animal-based EPA/DHA, emphasizing that only the latter provide meaningful metabolic benefits. Plant-based ALA converts very poorly into EPA/DHA, making direct consumption of animal sources (like fatty fish or pasture-raised meats) crucial for those seeking metabolic improvement. Dr. Bikman then explores how EPA and DHA enhance fat burning by stimulating mitochondrial biogenesis and improving mitochondrial efficiency. They increase the expression of CPT1 (the fat-shuttling enzyme) and promote mitochondrial uncoupling through UCP1 and UCP3, helping the body burn more fat—even at rest. He also describes how omega-3s…

Listen Ad-Free: https://benbikman.com In this Metabolic Classroom mini lecture, Dr. Bikman explores the powerful effects of ketones—particularly beta-hydroxybutyrate (BHB)—on the cardiovascular system. While ketones are typically thought of as a backup fuel, Ben explains how they are, in fact, an adaptive and efficient energy source that can support heart function in both healthy and failing states. Ben breaks down groundbreaking studies showing that ketones increase cardiac output, reduce vascular resistance, and improve heart function—especially in heart failure cases. He highlights the unique ability of BHB to reduce “afterload,” or the resistance the heart must pump against, effectively easing the heart’s workload. He also details ketones’ role in promoting vasodilation by acting on endothelial cells and smooth muscle, increasing nitric oxide and improving overall circulation. Beyond fuel metabolism, BHB also acts as a signaling molecule with epigenetic and anti-inflammatory effects. It can modulate gene…

Listen Ad-Free: https://benbikman.com In this mini-lecture, Ben explores the biochemical and physiological differences between plant and animal proteins—avoiding environmental or ethical debates and focusing strictly on metabolism and human health. He breaks down essential amino acids, emphasizing that animal proteins are "complete" sources, while most plant proteins fall short—particularly in leucine, which is vital for muscle protein synthesis. Dr. Bikman also discusses digestibility and bioavailability, explaining why animal proteins are more efficiently absorbed than plant sources. He introduces the DIAAS scoring system and details studies showing how much less effective plant proteins are at raising amino acid levels in the blood compared to animal proteins like pork or eggs. Importantly, the lecture addresses “antinutrients” in plant proteins—like trypsin inhibitors, phytates, and lectins—which impair protein digestion and mineral absorption. These antinutrients are also implicated in autoimmune…

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com 📢 Become an Insider, Ben’s website: https://www.benbikman.com In this lecture, Dr. Bikman explores how ketogenesis—our body's ability to produce ketones from fat—operates differently in men and women. While the foundational metabolic machinery is the same, hormonal influences, fat distribution, and physiological demands like pregnancy and lactation create meaningful divergences in how each sex mobilizes fat and enters ketosis. Women typically exhibit higher levels of free fatty acids and ketones during fasting compared to men. Estrogen drives this effect by enhancing both fat storage in subcutaneous areas and the enzymes responsible for fat breakdown. This dual effect—storing fat in a metabolically healthy way and releasing it efficiently when needed—makes women more metabolically flexible, especially during periods of energy demand like…

📢 Ask Dr. Bikman’s Digital Mind: https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com 📢 Become an Insider, Ben’s website: https://www.benbikman.com In this mini lecture Dr. Bikman explores how concussions cause more than just structural damage to the brain—they create a serious metabolic energy crisis. A concussion reduces the brain’s ability to use glucose by impairing glucose transporters and glycolytic enzymes, leaving neurons starved for energy just when demand spikes. This disruption persists even after initial symptoms fade and can worsen inflammation and oxidative stress, further harming brain function. Fortunately, ketones provide a powerful alternative energy source. Unlike glucose, ketones can bypass the damaged pathways and fuel the brain directly via mitochondria, improving ATP production, reducing oxidative stress, and modulating inflammation. Both ketogenic diets and exogenous ketones (like goBHB) can dramatically improve…

📢 Ask Dr. Bikman’s Digital Mind: https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com 📢 Become an Insider, Ben’s website: https://www.benbikman.com In this Metabolic Classroom lecture, Dr. Bikman explains the crucial role of plasmalogens—a unique type of fat found in the membranes of cells, especially in metabolically active tissues like the brain, heart, and fat cells. These special fats help keep cells flexible, support insulin signaling, protect against oxidative stress, and even regulate energy production by stabilizing mitochondria. Dr. Bikman details how plasmalogens act as “sacrificial shields” to defend cells from damage and how they enable cell signaling by keeping membranes fluid. Ben explores how plasmalogens directly impact fat cell behavior, enabling white fat to transform into more metabolically active beige fat. This shift enhances fat burning and improves insulin sensitivity. In fat cells and mitochondria alike,…

visit: https://www.benbikman.com visit: https://insuliniq.com In this Metabolic Classroom lecture, Dr. Bikman explores the deep biochemical relationship between stress and ketone production, uncovering how the body interprets stress signals as cues to mobilize fat and create ketones. He explains how stress hormones—like epinephrine, cortisol, glucagon, and growth hormone—aren’t just emergency signals but actually metabolic adaptation hormones that help the body shift into fat-burning mode. Through the sympathetic nervous system and hormone cascades, the body responds to stress by increasing lipolysis and triggering ketogenesis, even during fasting, exercise, or low-carb eating. Ben walks through how ketogenesis begins at the level of fat cells and liver mitochondria, and how key molecules like acetyl-CoA and oxaloacetate determine whether the body makes glucose or ketones. Importantly, he clarifies that while stress can trigger positive metabolic shifts, chronic stress without relief can lead to harmful…

📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com 📢 Become an Insider, Ben’s website: https://www.benbikman.com In this Metabolic Classroom lecture, Dr. Bikman explores the often-overlooked but metabolically vital glycocalyx—a carbohydrate-rich layer coating nearly every cell in the human body. Far from being just a structural feature, the glycocalyx influences nutrient absorption, immune response, vascular function, inflammation, and even how fat cells grow and behave. Ben explains how this sugar-rich matrix is built from glycoproteins and glycosaminoglycans and how it's found in tissues like the gut, blood vessels, and fat cells, each playing unique roles. In the gut, it controls nutrient permeability and helps block pathogens. In blood vessels, it regulates nitric oxide release, controls protein leakage, and reduces the risk of clotting or atherosclerosis. And in fat cells, it influences cell growth, fuel handling, and inflammation. Importantly, metabolic dysfunction—especially…

📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com 📢 Become an Insider, Ben’s website: https://www.benbikman.com In this episode of Metabolic Classroom, Ben Bikman takes a detailed look at the pancreas, a small but mighty organ with two major roles—endocrine and exocrine. The endocrine pancreas (just 1–2% of its mass) regulates metabolism by secreting hormones like insulin, glucagon, somatostatin, pancreatic polypeptide, and ghrelin. These hormones work together in a push-pull fashion to control blood sugar, fat storage, appetite, and nutrient use. Importantly, the flow of blood from endocrine tissue directly into the exocrine portion of the pancreas allows these hormones to rapidly influence digestion—a unique design seen in few other organs. Dr. Bikman explains that the exocrine pancreas (about 98% of the organ) produces powerful digestive juices that include enzymes for breaking down carbohydrates, fats, and proteins. This fluid is rich in bicarbonate to neutralize stomach acid…

📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com 📢 Become an Insider, Ben’s website: https://www.benbikman.com In this foundational Metabolic Classroom lecture, Dr. Ben Bikman unpacks the vital role of the autonomic nervous system (ANS) in maintaining health and metabolic balance. The ANS, a part of the peripheral nervous system, regulates involuntary processes such as heart rate, digestion, respiratory rate, and blood pressure—largely without conscious control. It's divided into two branches: the sympathetic (fight or flight) and parasympathetic (rest and digest) systems. Dr. Bikman first explains how the sympathetic system is designed to mobilize energy quickly through hormones like epinephrine. While short-term activation (like during exercise or danger) is beneficial, prolonged sympathetic activity—known as sympathetic overdrive—can lead to insulin resistance, mitochondrial stress, oxidative damage, and fat accumulation in organs like the liver and muscle. Conversely, the…